Klein Matthew B. 4
4 · PTC THERAPEUTICS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Klein Matthew B.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2026-01-02+63,000→ 405,132 total - Award
Stock Option (Right to Buy)
2026-01-02+157,500→ 157,500 totalExercise: $76.74Exp: 2036-01-01→ Common Stock (157,500 underlying)
Footnotes (3)
- [F1]Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.
- [F2]Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.
- [F3]This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.